April 14, 2021
Business News

Veracyte Announces Fourth Quarter and Full-Year 2020 Financial Results

SOUTH SAN FRANCISCO, Calif.–()–Veracyte, Inc. (Nasdaq: VCYT) today announced financial results for the fourth quarter and full year ended December 31, 2020 and provided an update on recent business progress.

“Our revenue and genomic testing and product volume continued to rebound from the pandemic during the fourth quarter and we entered 2021 with strong momentum across our business,” said Bonnie Anderson, Veracyte’s chairman and chief executive officer. “We are on track to launch multiple new products this year, including our noninvasive nasal swab test and Percepta Genomic Atlas in lung cancer.

“Additionally, we expect our pending acquisition of Decipher Biosciences, with its market-leading products…

Click here to view the original article.

Related Posts

You might also like ...

Riassunto: Velodyne propone le sue avanzate soluzioni lidar al salone dell’automobile Auto Shanghai 2021
L3Harris Technologies and American Rheinmetall Vehicles Team to Pursue US Army’s New Fighting Vehicle
ADAPTHEALTH ALERT: Bragar Eagel & Squire, P.C. Is Investigating AdaptHealth Corporation on Behalf AdaptHealth Stockholders and Encourages Investors to Contact the Firm